Luyan Pharma Co.,Ltd.’s Net Profit Rose 12.2% in First Half of 2023

Luyan Pharma Co.,Ltd. (鹭燕医药股份有限公司) (002788.SZ) reported a net profit of 190.1 million yuan in the first half of 2023, up 12.2% year-on-year.

Meanwhile, the company posted 10 billion yuan in revenue, up 7.3% year-on-year.

At the end of the reporting period, it had 11.5 billion yuan in total assets and 8.6 billion yuan in total liabilities, with a liability-to-asset ratio of 75.2%.